Repro-Med Systems, Inc. Ownership
$3.19
0.31%
Nasdaq, Sep 17, 02:20 pm EDT.
Market open.
Index
Industry
Repro-Med Systems, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Horton Capital Management LLC
|
9.775m | 21.18% | -876.758k | Feb 24 2023 |
| 2 |
First Light Asset Management, LLC
|
6.338m | 13.73% | +64.309k | Dec 31 2022 |
| 3 |
Archon Capital Management LLC
|
2.970m | 6.43% | — | Dec 31 2022 |
| 4 |
Frommer (Kathy S)
|
1.735m | 3.76% | +5.221k | Mar 31 2022 |
| 5 |
The Vanguard Group, Inc.
|
1.347m | 2.92% | +678.000 | Dec 31 2022 |
|
1
Horton Capital Management LLC
|
21.18%
9.775m
|
|
2
First Light Asset Management, LLC
|
13.73%
6.338m
|
|
3
Archon Capital Management LLC
|
6.43%
2.970m
|
|
4
Frommer (Kathy S)
|
3.76%
1.735m
|
|
5
The Vanguard Group, Inc.
|
2.92%
1.347m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 48.03% of Repro-Med Systems, Inc., with Horton Capital Management LLC the biggest at 21.18%, followed by First Light Asset Management, LLC (13.73%) and Archon Capital Management LLC (6.43%). |
Recent Repro-Med Systems, Inc. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Sep 17 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Sep 14 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 10 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 05 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Aug 30 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Aug 23 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Sep 17 2026
$182.45
|
|
Sarah Chen
SALES
|
Sep 14 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 10 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 05 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Aug 30 2026
$170.50
|
|
Lisa Park
SALES
|
Aug 23 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Repro-Med Systems, Inc. Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Repro-Med Systems, Inc. has fallen over the past 12 months from around 3.8% to 2.3% of the float. Fewer and fewer market participants are betting on falling prices. That points to easing skepticism, as short sellers increasingly unwind their positions. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
